# Study of AMG 650 in Adult Participants With Advanced Solid Tumors

Source: https://onco.cc/trials/nct04293094/  
OnCo record `nct04293094` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of Sovilnesib run by Volastra Therapeutics, Inc., completed.

## Summary

Study of AMG 650 in Adult Participants With Advanced Solid Tumors is a phase 1 interventional study registered as NCT04293094 by Volastra Therapeutics, Inc., with 66 participants enrolled, started 2020-03-11, primary completion reached 2022-10-24. Conditions recorded: Advanced Solid Tumors. Interventions recorded: AMG 650.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-04
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04293094
- Phase: 1
- Setting: A Phase 1, Multicenter, Open-label, Dose-Exploration and Dose-Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 650 in Subjects With Advanced Solid Tumors
- Sponsor: Volastra Therapeutics, Inc.
- Enrolled: 66

## Sources

- ClinicalTrials.gov NCT04293094: https://clinicaltrials.gov/study/NCT04293094

## Connected records

- drugs: [Sovilnesib](https://onco.cc/drugs/sovilnesib/)
- companies: [Volastra Therapeutics](https://onco.cc/companies/volastra-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/nct04293094.json